H&L (1781.TWO) monthly revenue, September 2026
H&L reported revenue of NT$0.03bn for September 2026, down 5.5% from the previous month and up 17.2% from a year earlier. Year-to-date revenue was NT$0.27bn, down 3.5% year on year. It ranked 59 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.03 | -5.5 | 17.2 |